Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.7814
-0.0116 (-1.46%)
Jun 18, 2025, 3:15 PM - Market open

Neumora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
1261,7132,604---
Upgrade
Market Cap Growth
-92.59%-34.22%----
Upgrade
Enterprise Value
-1201,3742,090---
Upgrade
Last Close Price
0.7910.6017.05---
Upgrade
PB Ratio
0.565.975.55---
Upgrade
P/TBV Ratio
0.565.975.55---
Upgrade
Debt / Equity Ratio
0.000.010.010.020.010.01
Upgrade
Quick Ratio
8.7910.2918.0815.7317.5920.50
Upgrade
Current Ratio
8.9810.5119.0516.3717.8520.69
Upgrade
Return on Equity (ROE)
-79.05%-64.48%-54.49%-32.67%-80.18%-106.02%
Upgrade
Return on Assets (ROA)
-48.50%-40.50%-25.50%-17.95%-16.01%-
Upgrade
Return on Capital (ROIC)
-52.09%-43.15%-26.75%-18.92%-16.84%-16.97%
Upgrade
Earnings Yield
-201.19%-14.24%-9.06%---
Upgrade
FCF Yield
-154.88%-10.68%-6.28%---
Upgrade
Buyback Yield / Dilution
-64.89%-145.12%-138.99%-24.25%-68.46%-
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q